CEO and Managing Director, Epilepsy Action Australia
Carol’s extensive background spans more than 35 years in the not-for-profit human services sector. She has been at the forefront of the medical cannabis movement in Australia. In her role at Epilepsy Action she has had significant contact with people faced with managing very challenging forms of medication resistant epilepsy, with few or no conventional options left. Carol has seen the changes in people’s lives, including reduction in the severity and frequency of seizures, resulting from use of medicinal cannabis. Carol serves on the Australian Advisory Council for the Use of Medicinal Cannabis, Advisory Board of The Lambert Initiative for Cannabinoid Therapeutics, Steering Committee for the NSW government’s Paediatric Epilepsy Trials (MC Research), Advisory Committee of Global Health International, and Medical Cannabis Council. She is a strong advocate for consumers.